Rituximab and Ibrutinib (RI) versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström’s Macroglobulinaemia (RAINBOW)
Is ibrutinib and rituximab a more effective first-line treatment than the current standard first-line treatment for people with WM?
Study to Evualate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants with B-Cell Malignancies
Assessing the safety and effectiveness of a medication called ABBV-101 in people with certain types of relapsed non-Hodgkin’s lymphomas
